BIOA (STOCKS)
BioAge Labs, Inc. Common Stock
$16.020000
-0.170000 (-1.05%)
Prev close: $16.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kristen Fortney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $718.06M
- Employees
- 64
- P/E (TTM)
- -7.22
- P/B (TTM)
- 2.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.72 | $-0.75 | +0.0336 | +4.46% |
|
Sep 2025 (Q3)
|
$-0.56 | $-0.60 | +0.0359 | +6.02% |
|
Jun 2025 (Q2)
|
$-0.60 | $-0.49 | -0.1096 | -22.35% |
|
Mar 2025 (Q1)
|
$-0.36 | $-0.54 | +0.1792 | +33.23% |
Financial Statements
| Revenues | $14.94M |
| Benefits Costs and Expenses | $117.05M |
| Cost Of Revenue | $22.32M |
| Costs And Expenses | $117.05M |
| Gross Profit | -$7.38M |
| Operating Expenses | $102.63M |
| Research and Development | $5.47M |
| Other Operating Expenses | $97.17M |
| Operating Income/Loss | -$110.01M |
| Income/Loss Before Equity Method Investments | -$102.11M |
| Income/Loss From Continuing Operations After Tax | -$102.19M |
| Income/Loss From Continuing Operations Before Tax | -$102.11M |
| Income Tax Expense/Benefit | $81.74K |
| Net Income/Loss | -$102.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$4.04M |
| Net Income/Loss Attributable To Parent | -$98.15M |
| Net Income/Loss Available To Common Stockholders, Basic | -$98.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.34 |
| Basic Average Shares | 41,948,030 |
| Assets | $69.51M |
| Current Assets | $15.25M |
| Inventory | $4.82M |
| Other Current Assets | $10.42M |
| Noncurrent Assets | $54.27M |
| Fixed Assets | $49.46M |
| Intangible Assets | $4.04M |
| Other Non-current Assets | $769.24K |
| Liabilities | $47.66M |
| Current Liabilities | $11.30M |
| Wages | $395.21K |
| Other Current Liabilities | $10.90M |
| Noncurrent Liabilities | $36.37M |
| Long-term Debt | $46.73M |
| Redeemable Noncontrolling Interest | $0.00 |
| Equity | $21.85M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $21.85M |
| Temporary Equity | $0.00 |
| Liabilities And Equity | $69.51M |
| Net Cash Flow From Operating Activities | -$29.79M |
| Net Cash Flow From Operating Activities, Continuing | -$29.79M |
| Net Cash Flow From Investing Activities | -$811.24K |
| Net Cash Flow From Investing Activities, Continuing | -$811.24K |
| Net Cash Flow From Financing Activities | $18.85M |
| Net Cash Flow From Financing Activities, Continuing | $18.85M |
| Exchange Gains/Losses | $224.04K |
| Net Cash Flow | -$11.53M |
| Net Cash Flow, Continuing | -$11.75M |
| Comprehensive Income/Loss | -$97.05M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$1.45M |
| Comprehensive Income/Loss Attributable To Parent | -$95.61M |
| Other Comprehensive Income/Loss | $5.13M |
| Other Comprehensive Income/Loss Attributable To Noncontrolling Interest | $2.59M |